| scholarly article | Q13442814 |
| P50 | author | Romain Gallet | Q56590121 |
| P2093 | author name string | Keiichi Fukuda | |
| Chak-Sum Ho | |||
| Debiao Li | |||
| Eduardo Marbán | |||
| Eleni Tseliou | |||
| Hideaki Kanazawa | |||
| James F Dawkins | |||
| Konstantinos Malliaras | |||
| Kristine Yee | |||
| Linda Marbán | |||
| Raj R Makkar | |||
| Rohan Dharmakumar | |||
| Ryan C Middleton | |||
| Geoffrey De Couto | |||
| Rachel R Smith | |||
| Michelle Kreke | |||
| Ileana Valle | |||
| P2860 | cites work | The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions | Q29615381 |
| Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation | Q30523741 | ||
| Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction | Q30570123 | ||
| Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators | Q32076921 | ||
| Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue | Q33506639 | ||
| The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance | Q34770962 | ||
| Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells | Q35666637 | ||
| Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 | ||
| Cardiac protection during acute myocardial infarction: where do we stand in 2004? | Q35840326 | ||
| Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction | Q36040528 | ||
| Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning | Q36288965 | ||
| Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection | Q36317528 | ||
| Targeting the inflammatory response in healing myocardial infarcts | Q36536484 | ||
| Clinical impact of left ventricular hypertrophy and implications for regression | Q37592362 | ||
| Mesenchymal Stem Cell Therapy for Cardiac Repair | Q37777383 | ||
| Measuring myocardial salvage | Q37981989 | ||
| Heart to heart: cardiospheres for myocardial regeneration | Q38027645 | ||
| Breakthroughs in cell therapy for heart disease: focus on cardiosphere-derived cells | Q38221422 | ||
| Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal S | Q38435541 | ||
| THY-1 receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential. | Q40476983 | ||
| Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction | Q41888608 | ||
| Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling | Q43852482 | ||
| Cardiac regeneration validated | Q44369507 | ||
| Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains | Q46052807 | ||
| Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. | Q47574001 | ||
| Molecular characterization of swine leucocyte antigen class I genes in outbred pig populations | Q47947194 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. | Q50689793 | ||
| Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. | Q51228456 | ||
| Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. | Q52945157 | ||
| Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. | Q53082410 | ||
| The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. | Q53824140 | ||
| Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial | Q69367792 | ||
| C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction | Q73606387 | ||
| Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction | Q77298898 | ||
| Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction | Q81435055 | ||
| Molecular characterization of swine leucocyte antigen class II genes in outbred pig populations | Q82732885 | ||
| Leukocyte count and incidence of hospitalizations due to heart failure | Q84646726 | ||
| Allogeneic adipose stem cell therapy in acute myocardial infarction | Q86973116 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2016-02-08 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction | |
| P478 | volume | 5 |
| Q64912607 | Age-Appropriateness of Porcine Models Used for Cell Transplantation. |
| Q47137765 | Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia. |
| Q58478037 | Cardiosphere-derived cells suppress allogeneic lymphocytes by production of PGE2 acting via the EP4 receptor |
| Q47363959 | Cortical Bone Stem Cells Administered at Reperfusion Attenuate Remote Zone Myocyte Remodeling. |
| Q48601122 | Cryopreservation of canine cardiosphere-derived cells: Implications for clinical application |
| Q93185062 | Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy |
| Q90310592 | Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models |
| Q38836140 | Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning. |
| Q50085056 | Exosomes and cardioprotection - A critical analysis |
| Q41104509 | Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction. |
| Q41247871 | Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy. |
| Q39412555 | Is Cardioprotection Dead? |
| Q92132391 | Macrophages in cardiac repair: Environmental cues and therapeutic strategies |
| Q37611026 | Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction |
| Q57176906 | New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types |
| Q30841694 | Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury |
| Q33722072 | Potency of Human Cardiosphere-Derived Cells from Patients with Ischemic Heart Disease Is Associated with Robust Vascular Supportive Ability |
| Q47104911 | Sex Differences of Human Cardiac Progenitor Cells in the Biological Response to TNF-α Treatment. |
| Q89638496 | The Effect of Cardiogenic Factors on Cardiac Mesenchymal Cell Anti-Fibrogenic Paracrine Signaling and Therapeutic Performance |
| Q36760792 | Widespread Intracoronary Cardiopoietic Cell Infusion: Treating at the Time of Myocardial Reperfusion to Prevent Rather Than Reverse Established Left Ventricular Dysfunction Moves Us Closer to Practical Clinical Translation |
Search more.